Accreditation Information
American Society of Andrology
2025 Joint Congress of The American Society of Andrology (ASA) and The International Congress of Andrology (ICA)
March 29, 2025 – April 1, 2025
Washington, DC
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Society of Andrology (ASA). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.
Professions in scope for this activity are listed below.
Physicians
Amedco LLC designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Objectives – After Attending This Program You Should Be Able To
1. Discuss the genetics and epigenetics of male infertility, infectious diseases and immune response, environmental factors and
post-testicular Influences on male reproductive health and fertility, male sexual dysfunction and surgical andrology, recent
developments in in vitro spermatogenesis and fertility preservation, androgen production across the lifespan.
2. Develop effective, cross-institutional and international collaborations across diverse areas of expertise.
3. Introduce novel and innovative models to address andrology field gaps.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5).
All individuals in a position to control the content of CE are listed below.
| Name | Commercial Interest:Relationship |
| John Amory | Celldex:Research Grant Site Principal Investigator |
| Anna-Maria Andersson | NA |
| Ki Aston | NA |
| Etienne Audet-Walsh | NA |
| Maria Agustina Battistone | NA |
| Hermann Behre | Merck:Speakers Bureau
Merck:Scientific/Medical Advisory Board Member Ferring:Research Grant Site Principal Investigator |
| Clemence Belleannee | NA |
| Helen Bernie | Boston Scientific, Coloplast, BK Medical:Consultant
Boston Scientific:Research Grant Overall Principal Investigator |
| Sudhanshu Bhushan | NA |
| Mariano Buffone | NA |
| Kevin Campbell | Tolmar Pharmaceuticals:Consultant |
| Judit Castillo | NA |
| Michal Chovanec | NA |
| Pierre Comizzoli | NA |
| Donald Conrad | Paterna Biosciences:Scientific/Medical Advisory Board Member |
| Giovanni Corona | NA |
| Patricia Cuasnicu | NA |
| Martine Culty | NA |
| Daniel Cyr | NA |
| Karine de Mattos | NA |
| Nathalie Dejucq-Rainsford | NA |
| Jannette Dufour | Sernova Corp:Stock Shareholder |
| Luca Gianaroli | NA |
| Nitzan Gonen | NA |
| Dimitrios Goulis | NA |
| Dimitrios Goulis | NA |
| Sue Hammoud | NA |
| Mark Peter Hedger | NA |
| Wayne Hellstrom | Gilead/Galapagos, Promescent, Maximus, Futura/Haleon:Scientific/Medical Advisory Board Member
Boston Scientific , Coloplast , Endo , Jazz Pharmaceuticals:Consultant Theralogix :Corporate Board Member |
| masahito ikawa | NA |
| Andrea Isidori | Recordati:Consultant
Kyowa-Kirin:Scientific/Medical Advisory Board Member Geoden Ricther , Neurocrine:Research Grant Site Principal Investigator |
| Tim Jenkins | Renew Biotechnologies:Owner |
| Joan Jorgensen | NA |
| Carolina Jorgez | NA |
| Aris Kaltsas | NA |
| Travis Kent | NA |
| Mohit Khera | Marius, Verity, Endo, Besins:Consultant
Boston Scientific , Petros:Scientific/Medical Advisory Board Member |
| Zine-Eddine KHERRAF | NA |
| Csilla Krausz | NA |
| Dolores Lamb | NA |
| Peter Liu | NA |
| Francesco Lotti | NA |
| Kate Loveland | NA |
| Guillermina Luque | NA |
| Daniel Marcu | NA |
| Andreas Meinhardt | NA |
| Rod Mitchell | NA |
| Edgar Mocanu | Merck:Speakers Bureau
Cryos:Scientific/Medical Advisory Board Member |
| Daniel Moreno Mendoza | NA |
| Makoto Nagano | NA |
| Katherine Nathanson | NA |
| Kyle Orwig | Paterna Biosciences:Scientific/Medical Advisory Board Member |
| Stephanie Page | Pharmajor:Consultant |
| Gianpiero Palermo | NA |
| Vassilios Papadopoulos | ACESIS Biomed:Corporate Board Member
GABA Therapeutics:Scientific/Medical Advisory Board Member |
| Juliana Perobelli | NA |
| Rita Rahban | NA |
| Ewa Rajpert-De Meyts | NA |
| Prabhakara Reddi | NA |
| Antoni Riera-Escamilla | NA |
| Andrea Salonia | NA |
| Andrea Sansone | NA |
| CELIA SANTIGRAUPEREZ | NA |
| stefan schlatt | NA |
| Peter Schlegel | Posterity Health, IGYXOS, ReproNovo, Xenetic Biosciences:Consultant
Roman Health:Private Stock Shareholder |
| Thad Schug | NA |
| Ege Can Serefoglu | Virility Medical Ltd:Stock Shareholder
Viatris Inc, Absorption Pharmaceuticals,, Kanna Health, Menarini :Consultant |
| Osama Shaeer | Coloplast, BSC, Rigicon:Consultant |
| Yuichi Shima | NA |
| Keisuke Shimada | NA |
| Mark Sigman | NA |
| Andrew Sinclair | NA |
| Peter Snyder | AbbVie:Research Grant Overall Principal Investigator |
| Ronald Swerdloff | NA |
| Anett Szabó | NA |
| Jolanta Słowikowska-Hilczer | NA |
| Raffaele Teperino | NA |
| Jorma Toppari | NA |
| Jacquetta Trasler | NA |
| Jacques J. Tremblay | NA |
| Akira Tsujimura | NA |
| Paul Turek | AlphaSperm, Inc:Owner
Contraline, Inc, Future Family, Inc, Inherent Biosciences, Inc, Arex Bioscience, Inc, Give Doximity, Inc:Public Stock Shareholder |
| Frank Tüttelmann | IBSA:Other |
| dirk vanderschueren | NA |
| Eric Vilain | NA |
| Pablo Visconti | NA |
| Donna Vogel | NA |
| Christina Wang | None:Research Grant Site Principal Investigator |
| Margot Julia Wyrwoll | NA |
| Wei Yan | NA |
| Tracy Sandstrom | NA |